Psychosis in Parkinson's Disease: Case Studies

Brian C. Salter; Karen E. Anderson; William J. Weiner

doi:10.1016/j.ncl.2006.01.003

Psychosis in Parkinson's Disease: Case Studies

Brian C. Salter, Karen E. Anderson, William J. Weiner

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with nonpharmacologic interventions or with decreasing doses of antiparkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.

Original language	English (US)
Pages (from-to)	363-369
Number of pages	7
Journal	Neurologic clinics
Volume	24
Issue number	2
DOIs	https://doi.org/10.1016/j.ncl.2006.01.003
State	Published - May 2006
Externally published	Yes

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1016/j.ncl.2006.01.003

Cite this

@article{eebacd6495444a969319156e4d823708,

title = "Psychosis in Parkinson's Disease: Case Studies",

abstract = "Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with nonpharmacologic interventions or with decreasing doses of antiparkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.",

author = "Salter, {Brian C.} and Anderson, {Karen E.} and Weiner, {William J.}",

year = "2006",

month = may,

doi = "10.1016/j.ncl.2006.01.003",

language = "English (US)",

volume = "24",

pages = "363--369",

journal = "Neurologic clinics",

issn = "0733-8619",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Psychosis in Parkinson's Disease

T2 - Case Studies

AU - Salter, Brian C.

AU - Anderson, Karen E.

AU - Weiner, William J.

PY - 2006/5

Y1 - 2006/5

N2 - Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with nonpharmacologic interventions or with decreasing doses of antiparkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.

AB - Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with nonpharmacologic interventions or with decreasing doses of antiparkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.

UR - http://www.scopus.com/inward/record.url?scp=33646202314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646202314&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2006.01.003

DO - 10.1016/j.ncl.2006.01.003

M3 - Review article

C2 - 16684637

AN - SCOPUS:33646202314

SN - 0733-8619

VL - 24

SP - 363

EP - 369

JO - Neurologic clinics

JF - Neurologic clinics

IS - 2

ER -

Psychosis in Parkinson's Disease: Case Studies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this